167 related articles for article (PubMed ID: 11910622)
1. Intrauterine application of progestins in hormone replacement therapy: a review.
Riphagen FE
Climacteric; 2000 Sep; 3(3):199-211. PubMed ID: 11910622
[TBL] [Abstract][Full Text] [Related]
2. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
[TBL] [Abstract][Full Text] [Related]
3. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
4. Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response.
Raudaskoski T; Tapanainen J; Tomás E; Luotola H; Pekonen F; Ronni-Sivula H; Timonen H; Riphagen F; Laatikainen T
BJOG; 2002 Feb; 109(2):136-44. PubMed ID: 11888095
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
6. Rationale for estrogen with interrupted progestin as a new low-dose hormonal replacement therapy.
Casper RF; MacLusky NJ; Vanin C; Brown TJ
J Soc Gynecol Investig; 1996; 3(5):225-34. PubMed ID: 8796834
[TBL] [Abstract][Full Text] [Related]
7. Intrauterine and subdermal progestin administration in postmenopausal hormone replacement therapy.
Suhonen SP; Holmström T; Allonen HO; Lähteenmäki P
Fertil Steril; 1995 Feb; 63(2):336-42. PubMed ID: 7843440
[TBL] [Abstract][Full Text] [Related]
8. Routes of delivery for progesterone and progestins.
Sitruk-Ware R
Maturitas; 2007 May; 57(1):77-80. PubMed ID: 17368973
[TBL] [Abstract][Full Text] [Related]
9. Progesterone, progestins and the endometrium in perimenopause and in menopausal hormone therapy.
Gompel A
Climacteric; 2018 Aug; 21(4):321-325. PubMed ID: 29583028
[TBL] [Abstract][Full Text] [Related]
10. Progestin replacement in the menopause: effects on the endometrium and serum lipids.
Williams DB; Moley KH
Curr Opin Obstet Gynecol; 1994 Jun; 6(3):284-92. PubMed ID: 8038417
[TBL] [Abstract][Full Text] [Related]
11. Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol.
Suvanto-Luukkonen E; Sundström H; Penttinen J; Kauppila A
Arch Gynecol Obstet; 1998; 261(4):201-8. PubMed ID: 9789651
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
[TBL] [Abstract][Full Text] [Related]
13. The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: a clinical review.
Depypere H; Inki P
Climacteric; 2015; 18(4):470-82. PubMed ID: 25553775
[TBL] [Abstract][Full Text] [Related]
14. Are progestins really necessary as part of a combined HRT regimen?
Sturdee DW
Climacteric; 2013 Aug; 16 Suppl 1():79-84. PubMed ID: 23651281
[TBL] [Abstract][Full Text] [Related]
15. Comparing the effects of intrauterine progestin system and oral progestin on health-related quality of life and Kupperman index in hormone replacement therapy.
Pirimoglu ZM; Ozyapi AG; Kars B; Buyukbayrak EE; Solak Y; Karsidag AY; Unal O; Turan MC
J Obstet Gynaecol Res; 2011 Oct; 37(10):1376-81. PubMed ID: 21599801
[TBL] [Abstract][Full Text] [Related]
16. Micronized progesterone and its impact on the endometrium and breast vs. progestogens.
Gompel A
Climacteric; 2012 Apr; 15 Suppl 1():18-25. PubMed ID: 22432812
[TBL] [Abstract][Full Text] [Related]
17. Three-year follow-up of the use of a levonorgestrel-releasing intrauterine system in hormone replacement therapy.
Suhonen S; Holmström T; Lähteenmäki P
Acta Obstet Gynecol Scand; 1997 Feb; 76(2):145-50. PubMed ID: 9049288
[TBL] [Abstract][Full Text] [Related]
18. Continuous combined parenteral estrogen substitution and intrauterine progestogen delivery: the ideal HST combination?
Wildemeersch D; Janssens D; Weyers S
Maturitas; 2005 Jun; 51(2):207-14. PubMed ID: 15917162
[TBL] [Abstract][Full Text] [Related]
19. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
Pike MC; Ross RK
Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
[TBL] [Abstract][Full Text] [Related]
20. HRT: developments in therapy.
Ellerington MC; Whitcroft SI; Whitehead MI
Br Med Bull; 1992 Apr; 48(2):401-25. PubMed ID: 1450877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
